Literature DB >> 3973982

In vitro mutagenesis of the promoter region for a vaccinia virus gene: evidence for tandem early and late regulatory signals.

M A Cochran, C Puckett, B Moss.   

Abstract

A vaccinia virus gene that is expressed throughout the reproductive cycle was found to have two sets of RNA start sites approximately 55 nucleotides apart. The site nearest to the coding segment is used early in infection and the one further upstream is used after DNA replication. A series of 5' to 3' deletions were made in the promoter region, and the truncated DNA segments were then ligated to the coding portion of the procaryotic chloramphenicol acetyltransferase gene to measure expression. The effects of these mutations on chloramphenicol acetyltransferase synthesis were determined in a vaccinia virus helper-dependent transient expression system and by forming infectious vaccinia virus recombinants that contain the chimeric genes. Deletions extending up to 31 nucleotides before the late RNA start site had no effect on either early or late expression. Removal of an additional 15 nucleotides produced a dramatic decrease in late expression but had no effect on early expression. The latter was not diminished until the deletion was extended from 31 to 24 nucleotides before the early RNA start site. These results were confirmed by transcriptional analyses. We concluded that this vaccinia virus gene has two promoters and that the regulatory signals for each are located within 31 nucleotides of their sites of transcription.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3973982      PMCID: PMC254756     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  A new pair of M13 vectors for selecting either DNA strand of double-digest restriction fragments.

Authors:  J Messing; J Vieira
Journal:  Gene       Date:  1982-10       Impact factor: 3.688

2.  Deletion mapping of DNA regions required for SV40 early region promoter function in vivo.

Authors:  M Fromm; P Berg
Journal:  J Mol Appl Genet       Date:  1982

3.  Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen.

Authors:  G L Smith; M Mackett; B Moss
Journal:  Nature       Date:  1983-04-07       Impact factor: 49.962

4.  Distinctive nucleotide sequences adjacent to multiple initiation and termination sites of an early vaccinia virus gene.

Authors:  S Venkatesan; B M Baroudy; B Moss
Journal:  Cell       Date:  1981-09       Impact factor: 41.582

5.  Complete nucleotide sequences of two adjacent early vaccinia virus genes located within the inverted terminal repetition.

Authors:  S Venkatesan; A Gershowitz; B Moss
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

6.  Initiation of adenovirus DNA replication in vitro requires a specific DNA sequence.

Authors:  F Tamanoi; B W Stillman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

7.  Vaccinia virus: a selectable eukaryotic cloning and expression vector.

Authors:  M Mackett; G L Smith; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

8.  Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters.

Authors:  G L Smith; B R Murphy; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

9.  Nucleotide sequence of the vaccinia virus thymidine kinase gene and the nature of spontaneous frameshift mutations.

Authors:  J P Weir; B Moss
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

10.  Simian virus 40 early mRNA's contain multiple 5' termini upstream and downstream from a Hogness-Goldberg sequence; a shift in 5' termini during the lytic cycle is mediated by large T antigen.

Authors:  P K Ghosh; P Lebowitz
Journal:  J Virol       Date:  1981-10       Impact factor: 5.103

View more
  95 in total

1.  Immediate-early expression of a recombinant antigen by modified vaccinia virus ankara breaks the immunodominance of strong vector-specific B8R antigen in acute and memory CD8 T-cell responses.

Authors:  Karen Baur; Kay Brinkmann; Marc Schweneker; Juliane Pätzold; Christine Meisinger-Henschel; Judith Hermann; Robin Steigerwald; Paul Chaplin; Mark Suter; Jürgen Hausmann
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

2.  In vitro recognition of an orf virus early promoter in a vaccinia virus extract.

Authors:  J C Vos; A A Mercer; S B Fleming; A J Robinson
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  IPTG-dependent vaccinia virus: identification of a virus protein enabling virion envelopment by Golgi membrane and egress.

Authors:  J F Rodriguez; G L Smith
Journal:  Nucleic Acids Res       Date:  1990-09-25       Impact factor: 16.971

4.  Simultaneous high-resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencing.

Authors:  Zhilong Yang; Daniel P Bruno; Craig A Martens; Stephen F Porcella; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

5.  Effects of a highly basic region of human immunodeficiency virus Tat protein on nucleolar localization.

Authors:  H Siomi; H Shida; M Maki; M Hatanaka
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

6.  Mutational analysis of the core, spacer, and initiator regions of vaccinia virus intermediate-class promoters.

Authors:  C J Baldick; J G Keck; B Moss
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

7.  Cascade regulation of vaccinia virus gene expression is modulated by multistage promoters.

Authors:  Zhilong Yang; Liliana Maruri-Avidal; Jerry Sisler; Carey A Stuart; Bernard Moss
Journal:  Virology       Date:  2013-10-03       Impact factor: 3.616

8.  Sequence and transcriptional analysis of an orf virus gene encoding ankyrin-like repeat sequences.

Authors:  J T Sullivan; K M Fraser; S B Fleming; A J Robinson; A A Mercer
Journal:  Virus Genes       Date:  1995-02       Impact factor: 2.332

9.  Poxviruses as Gene Therapy Vectors: Generating Poxviral Vectors Expressing Therapeutic Transgenes.

Authors:  Steven J Conrad; Jia Liu
Journal:  Methods Mol Biol       Date:  2019

10.  Hemorrhage in lesions caused by cowpox virus is induced by a viral protein that is related to plasma protein inhibitors of serine proteases.

Authors:  D J Pickup; B S Ink; W Hu; C A Ray; W K Joklik
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.